Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Arvinas, Inc.
arvinas.comAI Executive Summary
AI-powered analysis of 8-K filing content
Arvinas, Inc. announced the departure of Chief Medical Officer Dr. Noah Berkowitz effective July 3, 2026, and has commenced a search for his successor. This leadership transition could impact the company's clinical and medical strategy execution.
Key Takeaways
Dr. Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, will depart Arvinas effective July 3, 2026
A separation agreement and release of claims was established between Dr. Berkowitz and the company on June 22, 2026
2 more takeaways
Related Filings (2)
2 more filings from Arvinas, Inc. in the last 90 days